CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 84% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.

Trade Natus - NTUS CFD

-
0%
  • Summary
  • Historical Data
  • Events
  • Income Statement
  • Balance Sheet
  • Cash Flow
  • Ownership
Trading Conditions
Spread -
Long position overnight fee

Long position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.024874 %
Charges from borrowed part ($-0.99)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00

Go to platform
-0.024874%
Short position overnight fee

Short position overnight fee


Margin. Your investment $1,000.00
Overnight fee 0.002651 %
Charges from borrowed part ($0.11)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00

Go to platform
0.002651%
Overnight fee time 21:00 (UTC)
Min traded quantity 1
Currency USD
Margin 20%
Stock exchange United States of America
Commission on trade 0%

*Information provided by Capital.com

Key Stats
Prev. Close* N/A
Open* N/A
1-Year Change* N/A
Day's Range* N/A
52 wk Range 20.90-33.93
Average Volume (10 days) N/A
Average Volume (3 months) 8.13M
Market Cap 1.14B
P/E Ratio 88.30
Shares Outstanding 34.58M
Revenue 478.30M
EPS 0.37
Dividend (Yield %) N/A
Beta 0.23
Next Earnings Date Aug 3, 2022

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low

Natus Events

Time (UTC) Country Event
No events scheduled
View all events
  • Annual
  • Quarterly
2021 2020 2019 2018 2017
Total revenue 473.438 415.684 495.175 530.891 500.97
Revenue 473.438 415.684 495.175 530.891 500.97
Cost of Revenue, Total 200.258 192.753 203.467 226.876 219.756
Gross Profit 273.18 222.931 291.708 304.015 281.214
Total Operating Expense 449.659 435.877 510.841 555.453 492.253
Selling/General/Admin. Expenses, Total 170.667 156.395 188.758 207.279 200.59
Research & Development 58.006 61.296 58.733 61.482 51.822
Depreciation / Amortization 15.129 15.224 15.144 22.585 19.171
Unusual Expense (Income) 5.599 10.209 44.739 37.231 0.914
Operating Income 23.779 -20.193 -15.666 -24.562 8.717
Interest Income (Expense), Net Non-Operating -3.742 -1.657 -5.456 -7.26 -3.643
Other, Net -0.682 -0.215 -0.135 -0.438 0.076
Net Income Before Taxes 19.355 -22.065 -21.257 -32.26 5.15
Net Income After Taxes 13.177 -16.613 -15.671 -14.335 0.207
Net Income Before Extra. Items 13.177 -16.613 -15.671 -14.335 0.207
Net Income 13.177 -16.613 -15.671 -22.935 -20.293
Income Available to Common Excl. Extra. Items 13.177 -16.613 -15.671 -14.335 0.207
Income Available to Common Incl. Extra. Items 13.177 -16.613 -15.671 -22.935 -20.293
Diluted Net Income 13.177 -16.613 -15.671 -22.935 -20.293
Diluted Weighted Average Shares 33.974 33.562 33.696 33.111 32.564
Diluted EPS Excluding Extraordinary Items 0.38786 -0.49499 -0.46507 -0.43294 0.00636
Diluted Normalized EPS 0.50005 -0.29147 0.39795 0.29794 0.0246
Total Extraordinary Items -8.6 -20.5
Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
Total revenue 119.793 128.656 113.877 115.978 114.927
Revenue 119.793 128.656 113.877 115.978 114.927
Cost of Revenue, Total 54.381 55.613 46.229 49.577 48.839
Gross Profit 65.412 73.043 67.648 66.401 66.088
Total Operating Expense 115.612 123.957 105.332 109.964 110.407
Selling/General/Admin. Expenses, Total 42.358 41.832 41.613 42.098 45.126
Research & Development 13.224 13.85 14.667 14.249 15.24
Depreciation / Amortization 3.598 3.632 3.681 3.919 3.897
Unusual Expense (Income) 2.051 9.03 -0.858 0.121 -2.695
Operating Income 4.181 4.699 8.545 6.014 4.52
Interest Income (Expense), Net Non-Operating -0.571 -0.884 -0.819 -0.543 -1.494
Other, Net -0.236 -0.185 -0.229 -0.108 -0.162
Net Income Before Taxes 3.374 3.63 7.497 5.363 2.864
Net Income After Taxes 1.903 1.744 5.573 3.464 2.396
Net Income Before Extra. Items 1.903 1.744 5.573 3.464 2.396
Net Income 1.903 1.744 5.573 3.464 2.396
Income Available to Common Excl. Extra. Items 1.903 1.744 5.573 3.464 2.396
Income Available to Common Incl. Extra. Items 1.903 1.744 5.573 3.464 2.396
Dilution Adjustment 0
Diluted Net Income 1.903 1.744 5.573 3.464 2.396
Diluted Weighted Average Shares 34.276 34.265 33.865 33.871 33.782
Diluted EPS Excluding Extraordinary Items 0.05552 0.0509 0.16457 0.10227 0.07093
Dividends per Share - Common Stock Primary Issue 0 0 0 0
Diluted Normalized EPS 0.08927 0.17751 0.14573 0.10458 0.00419
  • Annual
  • Quarterly
2021 2020 2019 2018 2017
Total Current Assets 277.291 271.702 269.749 285.775 305.628
Cash and Short Term Investments 75.595 82.082 63.297 56.373 88.95
Cash & Equivalents 75.595 82.082 63.297 56.373 88.95
Short Term Investments 0
Total Receivables, Net 111.76 93.133 115.889 127.041 126.809
Accounts Receivable - Trade, Net 111.76 93.133 115.889 127.041 126.809
Total Inventory 67.745 75.65 71.368 79.736 71.529
Prepaid Expenses 22.191 20.837 19.195 22.625 18.34
Total Assets 564.288 600.394 622.527 638.14 709.919
Property/Plant/Equipment, Total - Net 31.071 36.185 39.748 22.913 22.071
Property/Plant/Equipment, Total - Gross 64.381 66.911 81.799 62.646 58.51
Accumulated Depreciation, Total -33.31 -30.726 -42.051 -39.733 -36.439
Goodwill, Net 148.657 151.299 146.367 147.644 172.998
Intangibles, Net 65.513 92.741 114.799 139.453 172.582
Other Long Term Assets, Total 41.756 48.467 51.864 42.355 36.64
Total Current Liabilities 114.601 145.752 142.821 133.446 92.137
Accounts Payable 36.405 23.429 27.253 28.805 25.242
Accrued Expenses 44.229 42.663 50.52 37.465 40.998
Notes Payable/Short Term Debt 0 0 0 0 0
Other Current Liabilities, Total 33.736 29.246 29.658 32.176 25.897
Total Liabilities 139.538 189.3 206.404 239.696 287.822
Total Long Term Debt 0.23 6.286 20.264 69.474 154.283
Long Term Debt 0 5.84 19.665 69.474 154.283
Deferred Income Tax 11.811 21.247 26.581 16.931 19.407
Other Liabilities, Total 12.896 16.015 16.738 19.845 21.995
Total Equity 424.75 411.094 416.123 398.444 422.097
Preferred Stock - Non Redeemable, Net 0 0 0 0 0
Common Stock 353.737 342.828 344.476 334.215 316.577
Retained Earnings (Accumulated Deficit) 84.486 71.309 87.922 102.261 129.115
Other Equity, Total -13.473 -3.043 -16.275 -38.032 -23.595
Total Liabilities & Shareholders’ Equity 564.288 600.394 622.527 638.14 709.919
Total Common Shares Outstanding 34.2257 33.9117 34.1487 33.8044 33.1341
Current Port. of LT Debt/Capital Leases 0.231 50.414 35.39 35
Capital Lease Obligations 0.23 0.446 0.599
Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
Total Current Assets 286.768 277.291 261.671 245.699 265.819
Cash and Short Term Investments 84.285 75.595 68.779 62.494 80.549
Cash & Equivalents 84.285 75.595 68.779 62.494 80.549
Total Receivables, Net 103.714 111.76 97.37 92.793 91.326
Accounts Receivable - Trade, Net 103.714 111.76 97.37 92.793 91.326
Total Inventory 72.238 67.745 71.545 68.35 69.467
Prepaid Expenses 26.531 22.191 23.977 22.062 24.477
Total Assets 568.083 564.288 561.251 556.218 581.368
Property/Plant/Equipment, Total - Net 29.418 31.071 32.783 34.498 34.058
Property/Plant/Equipment, Total - Gross 63.894 64.381 64.807 65.284 63.609
Accumulated Depreciation, Total -34.476 -33.31 -32.024 -30.786 -29.551
Goodwill, Net 148.304 148.657 149.293 150.482 149.761
Intangibles, Net 59.815 65.513 73.602 80.054 85.001
Other Long Term Assets, Total 43.778 41.756 43.902 45.485 46.729
Total Current Liabilities 112.855 114.601 103.801 102.463 136.476
Accounts Payable 34.342 36.405 28.322 26.892 24.486
Accrued Expenses 51.667 53.099 49.742 51.106 51.798
Notes Payable/Short Term Debt 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 0 0 0 36.523
Other Current Liabilities, Total 26.846 25.097 25.737 24.465 23.669
Total Liabilities 137.189 139.538 138.729 138.391 172.436
Total Long Term Debt 0 0 0 0 0
Long Term Debt 0 0 0 0
Deferred Income Tax 1.451 1.133 9.826 10.038 9.915
Other Liabilities, Total 22.883 23.804 25.102 25.89 26.045
Total Equity 430.894 424.75 422.522 417.827 408.932
Preferred Stock - Non Redeemable, Net 0 0 0 0 0
Common Stock 359.319 353.737 350.457 347.818 344.696
Retained Earnings (Accumulated Deficit) 86.389 84.486 82.742 77.169 73.705
Other Equity, Total -14.814 -13.473 -10.677 -7.16 -9.469
Total Liabilities & Shareholders’ Equity 568.083 564.288 561.251 556.218 581.368
Total Common Shares Outstanding 34.5761 34.2257 34.1526 34.1321 34.0969
  • Annual
  • Quarterly
2021 2020 2019 2018 2017
Net income/Starting Line 13.177 -16.613 -15.671 -22.935 -20.293
Cash From Operating Activities 63.995 34.426 60.06 33.02 19.726
Cash From Operating Activities 28.091 28.115 30.722 33.863 30.098
Deferred Taxes -4.386 -1.577 -5.364 -13.714 4.032
Non-Cash Items 19.793 23.078 37.842 49.912 26.485
Cash Taxes Paid 3.782 6.825 6.445 9.247 5.74
Cash Interest Paid 1.18 3.11 4.58 6.169 4.464
Changes in Working Capital 7.32 1.423 12.531 -14.106 -20.596
Cash From Investing Activities -1.946 -12.606 -5.339 -8.389 -160.935
Capital Expenditures -3.62 -8.609 -5.339 -8.54 -4.066
Other Investing Cash Flow Items, Total 1.674 -3.997 0 0.151 -156.869
Cash From Financing Activities -60.662 -10.877 -48.532 -49.512 5.826
Financing Cash Flow Items -4.107 -3.169 -1.689 -5.33 -10.372
Issuance (Retirement) of Stock, Net 0.855 -9.181 3.635 5.818 1.198
Issuance (Retirement) of Debt, Net -57.41 1.473 -50.478 -50 15
Foreign Exchange Effects -7.874 7.842 0.735 -7.696 10.782
Net Change in Cash -6.487 18.785 6.924 -32.577 -124.601
Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
Net income/Starting Line 1.903 13.177 11.433 5.86 2.396
Cash From Operating Activities 8.897 63.995 51.212 44.096 24.703
Cash From Operating Activities 6.673 28.091 21.337 14.45 7.257
Deferred Taxes -0.119 -4.386 1.06 1.106 1.064
Non-Cash Items 4.291 19.793 8.997 7.2 3.706
Cash Taxes Paid 1.066 3.782 3.172 1.671 -0.32
Cash Interest Paid 0.114 1.18 1.065 0.86 0.513
Changes in Working Capital -3.851 7.32 8.385 15.48 10.28
Cash From Investing Activities -1.634 -1.946 -1.275 -2.967 -0.731
Capital Expenditures -1.062 -3.62 -2.949 -1.967 -0.731
Cash From Financing Activities 2.516 -60.662 -57.968 -57.848 -21.275
Financing Cash Flow Items -1.228 -4.107 -1.254 -1.244 -1.15
Issuance (Retirement) of Stock, Net 4.191 0.855 0.612 0.612 0
Issuance (Retirement) of Debt, Net -0.447 -57.41 -57.326 -57.216 -20.125
Foreign Exchange Effects -1.089 -7.874 -5.272 -2.869 -4.23
Net Change in Cash 8.69 -6.487 -13.303 -19.588 -1.533
Other Investing Cash Flow Items, Total -0.572 1.674 1.674 -1

Why choose Capital.com? Our numbers speak for themselves.

Capital.com Group

500K+

Traders

92K+

Active clients monthly

$53M+

Monthly investing volume

$30M+

Withdrawn each month

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

Natus Company profile

About Natus Medical Inc

Natus Medical Incorporated provides healthcare solutions focused on the diagnosis and treatment of central nervous and sensory system disorders for patients of all ages. The Company provides product solutions for three end markets: Neuro, Newborn Care and Hearing & Balance. Its Neuro includes products and services that provide diagnostic, therapeutic and surgical solutions in neurodiagnostics, neurocritical care and neurosurgery. Its Newborn Care includes products and services for newborn care, including hearing screening, brain monitoring, eye imaging, jaundice management and various disposable newborn care supplies. Its Hearing portfolio includes products for hearing assessment and diagnostics and hearing aid fitting, including computer-based audiological, otoneurologic and vestibular instrumentation for hearing care professionals. Its Balance portfolio provides diagnosis and assessment of vestibular and balance disorders.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, Natus Medical Inc revenues increased 14% to $473.4M. Net income totaled $13.2M vs. loss of $16.6M. Revenues reflect Neurology Products - Devices and Systems segment increase of 23% to $220.9M, Audiology Products - Devices and Systems segment increase of 11% to $78.7M, United States segment increase of 13% to $286M, Foreign countries segment increase of 15% to $187.5M.

Equity composition

Common Stock $.001 Par, 04/11, 120M auth., 28,974,250 issd. Insiders control approx. 2.98%. IPO 7/20/01: 4,500,000 shs.@ $11 by Dain Rauscher Wessels Inc. FY'02 Q's are reclassified. FY'03-'04 Q's restated for discont.

Industry: Advanced Medical Equipment & Technology (NEC)

3150 Pleasant View Road
MIDDLETON
WISCONSIN 53562
US

Income Statement

  • Annual
  • Quarterly

News

A file photo shows a part of a stack of 500 Canadian gold coins, worth $1 million USD according to Sprott Money, is displayed at the precious metals dealer's booth at the Prospectors and Developers Association of Canada (PDAC) annual conference in Toronto

PRECIOUS-Fed slowdown bets steer gold toward second quarterly rise

Gold prices slipped on Friday, but the safe-haven metal was bound for its second straight quarterly rise after recent banking turmoil raised hopes of a less-aggressive U.S. Federal Reserve and shored up interest in bullion.

09:37, 31 March 2023
People use DBS automated teller machines (ATMs) in Singapore March 31, 2022.

Singapore's DBS has seen inflows in SVB aftermath, CEO says

DBS Group, Singapore's largest bank, has benefited from inflows amounting to a "few hundred millions" in the aftermath of the collapse of Silicon Valley Bank, its chief executive said on Friday.

09:24, 31 March 2023
Traders work on the floor of the New York Stock Exchange (NYSE) in New York City, U.S., March 29, 2023.

US STOCKS-Futures muted as investors await key inflation data

U.S. stock index futures were flat on Friday as investors steered clear of big bets ahead of crucial inflation data, amid receding fears of a banking crisis.

09:16, 31 March 2023
A file photo of the logo of Australian energy company Origin pictured in Melbourne, Australia, July 3, 2016

Asia M&As drop to decade low as tumultuous backdrop deters dealmaking

Mergers and acquisitions (M&A) in the Asia-Pacific region fell to a decade low in the first three months of this year as a tumultuous geopolitical and macroeconomic environment left dealmakers cautious.

09:14, 31 March 2023
A file photo of a worker shoveling coal in a supply truck at a yard on the outskirts of Ahmedabad, India, October 25, 2018.

Coal India surpasses annual output target for first time in 17 years

Coal India Ltd said on Friday it had breached its annual production target of 700 million tonnes, the first time it had surpassed its goal since the fiscal year that ended in March 2006.

09:13, 31 March 2023
A file photo of bull and bear symbols in front of the German stock exchange in Frankfurt, Germany, February 12, 2019.

Global IPOs marred by banks and recession enjoy few bright spots

A banking crisis and worries of a recession have dampened the outlook for initial public offerings (IPOs) this year, prompting companies to slow down their plans to go public in what is likely to result in lower fees for investment banks.

09:06, 31 March 2023
A file photo of Unicredit Bank logo seen in this illustration taken March 12, 2023.

UniCredit shareholders gather to vote on CEO's new pay scheme

Shareholders in UniCredit met on Friday to vote on a new pay scheme for Chief Executive Andrea Orcel designed to reward outperformance with a 30% pay raise.

09:04, 31 March 2023

People also watch

US100

13,186.80 Price
+1.680% 1D Chg, %
Long position overnight fee -0.0249%
Short position overnight fee 0.0027%
Overnight fee time 21:00 (UTC)
Spread 3.0

Oil - Crude

75.76 Price
+1.830% 1D Chg, %
Long position overnight fee -0.0156%
Short position overnight fee -0.0063%
Overnight fee time 21:00 (UTC)
Spread 0.03

Gold

1,969.66 Price
-0.550% 1D Chg, %
Long position overnight fee -0.0185%
Short position overnight fee 0.0102%
Overnight fee time 21:00 (UTC)
Spread 0.30

Natural Gas

2.20 Price
+3.540% 1D Chg, %
Long position overnight fee -0.4044%
Short position overnight fee 0.3825%
Overnight fee time 21:00 (UTC)
Spread 0.005

Still looking for a broker you can trust?

Join the 500.000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading